|
|
Volumn 9, Issue 6, 2007, Pages 430-435
|
|
Effects of candesartan and lisinopril on the fibrinolytic system in hypertensive patients.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BENZIMIDAZOLE DERIVATIVE;
CANDESARTAN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
LISINOPRIL;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
TETRAZOLE DERIVATIVE;
TISSUE PLASMINOGEN ACTIVATOR;
ADULT;
ARTICLE;
BLOOD;
BLOOD PRESSURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
ENZYMOLOGY;
FEMALE;
FIBRINOLYSIS;
HUMAN;
HYPERTENSION;
MALE;
MIDDLE AGED;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
BENZIMIDAZOLES;
BLOOD PRESSURE;
DOUBLE-BLIND METHOD;
FEMALE;
FIBRINOLYSIS;
HUMANS;
HYPERTENSION;
LISINOPRIL;
MALE;
MIDDLE AGED;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
PROSPECTIVE STUDIES;
TETRAZOLES;
TISSUE PLASMINOGEN ACTIVATOR;
|
|
EID: 34447285262
PISSN: 15246175
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1524-6175.2007.06506.x Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
